During the past decade, Ecogene-21 conducted 34 clinical trials. In the 10-year time frame, 34 clinical trials started and 18 clinical trials were completed, i.e. on average, 52.9% percent of trials that started reached the finish line to date. In the past 5 years, 23 clinical trials started and 10 clinical trials were completed. i.e. 43.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ecogene-21" #1 sponsor was "Pfizer" with 12 trials, followed by "Ionis Pharmaceuticals, Inc." with 6 trials sponsored, "Arrowhead Pharmaceuticals" with 4 trials sponsored, "Amgen" with 3 trials sponsored and "Eli Lilly and Company" with 3 trials sponsored. Other sponsors include 9 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ecogene-21" #1 collaborator was "Akcea Therapeutics" with 1 trials as a collaborator, "Brigham and Women's Hospital" with 1 trials as a collaborator, "Cyclerion Therapeutics" with 1 trials as a collaborator, "Duke Clinical Research Institute" with 1 trials as a collaborator and "National Heart, Lung, and Blood Institute (NHLBI)" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Ecogene-21" are "Cardiovascular Disease" (4 trials), "Severe Hypertriglyceridemia" (4 trials), "Dyslipidemias" (3 trials), "Familial Chylomicronemia Syndrome" (3 trials) and "Homozygous Familial Hypercholesterolemia" (3 trials). Many other conditions were trialed in "Ecogene-21" in a lesser frequency.

Most popular intervention types in "Ecogene-21" are "Drug" (40 trials) and "Other" (5 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (27 trials), "Olezarsen" (5 trials), "ARO-APOC3" (3 trials), "Bococizumab (PF-04950615;RN316)" (3 trials) and "PF-05221304" (3 trials). Other intervention names were less common.

The vast majority of trials in "Ecogene-21" are 41 trials for "All" genders.

Currently, there are NaN active trials in "Ecogene-21". undefined are not yet recruiting, 6 are recruiting, 9 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 19 completed trials in Ecogene-21, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Ecogene-21, 1 "Phase 1" clinical trials were conducted, 19 "Phase 2" clinical trials and 17 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".